Overview


According to FutureWise analysis the market for Antibacterial Haemostatic Gels in 2023 is US$ 1.4 billion, and is expected to reach US$ 2.34 billion by 2031 at a CAGR of 6.60%.

The antibacterial haemostatic gels are used to stop the bleeding or hemorrhage caused by wounds or surgical processes. These gels have antibacterial properties, which prevent the growth of bacteria near the gel. They often contain ingredients that promote blood clotting, helping to staunch bleeding from wounds or surgical sites. This is particularly important in situations where wounds are prone to infection. Combining haemostatic and antibacterial properties in one product can be particularly beneficial because it addresses the immediate need to stop bleeding and the longer-term need to prevent or treat infections that can complicate wound healing.

Antibacterial haemostatic gels have several applications in urinalysis testing, hematology testing, and blood pressure monitoring. Urinalysis, also known as urine testing, is a diagnostic tool used to evaluate different characteristics of an individual's health by analyzing the chemical composition of the urine. It is one of the most standard diagnostic tests performed in medicine. This involves a visual examination of the urine sample for color, clarity, and any unusual attributes such as cloudiness, foaming, or particles. It also helps diagnose and monitor ailments like diabetes, kidney disease, urinary tract infections, and liver diseases. Additionally, it is commonly used in drug testing programs for workplaces, sports clubs, and legal proceedings.

FutureWise Market Research has published a report that provides an insightful analysis antibacterial haemostatic gels market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antibacterial haemostatic gels market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Medura
  • Zoetis Inc.
  • IDEXX laboratories inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)
 

Recent Developments in Antibacterial Haemostatic Gels Market:

  • In July 2021, Rapid-Seal, a high-performance, antibacterial haemostatic gel, was introduced by Medcura, which partnered with ASO, LLC, a significant US supplier of first-aid items. This product is available at a large US pharmacy chain.

The increasing incidence of surgical procedures globally is anticipated to fuel the growth of the antibacterial haemostatic gels market. As healthcare advancements foster a wider spectrum of surgical treatments, the demand for effective bleeding control becomes essential. Antibacterial haemostatic gels play a vital role, offering a reliable solution to swiftly and effectively control bleeding during surgeries. These application provides patient safety by alleviating extreme bleeding and contributes to optimized surgical procedures, thus enhancing overall surgical results. In addition, the growing awareness about the potential risks associated with post-surgical infections has increased the demand for antibacterial products, especially haemostatic gels. Infection control is a major concern in the healthcare sector, as complications occurring from surgical site infections may lead to long hospital stays, increased healthcare expenses, and life-threatening consequences for patients. With antibacterial properties, haemostatic gels act as a proactive shield against these threats. By controlling bleeding and reducing the chances of infections, these gels play a vital role in preventing post-operative intricacies, further boosting the target market over the projection period. However, the high cost of advanced formulations may restrain the widespread adoption of antibacterial haemostatic gels. While these advanced formulations offer enhanced efficiency and benefits, they often come at a premium price, restricting healthcare facilities with budget constraints. They may also face obstacles leading to more cost-effective- alternatives and traditional methods. Therefore, hindering the growth of the target market.

By Product Type

  • Urinanalysis Testing Kits
  • Hematology Testing Kits
  • Blood Pressure Monitoring Devices
  • Blood Glucose Monitoring Devices
  • Others

By Animal Type

  • Cats
  • Dogs
  • Horses
  • Others

By End-User

  • Homecare
  • Diagnostic Centres
  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to factors such as an increased number of surgeries, availability of a wide range range of hemostatic gel products, growing geriatric population which is prone to chronic diseases and injuries, increased cases of routine injuries and wounds among the individuals, and the high risk of infections associated with wounds are anticipated to boost the sales of antibacterial haemostatic gels market during the forecast period. In addition, the presence of major players using different strategies like acquisition, mergers, and collaborations to increase the brand presence is further propelling the target market. For instance, in December 2022, Medcura Inc. announced that Walmart would be selling the company's antibacterial wound gel Rapid Seal through Walmart.com. The rapid seal is the bleeding management and hemostatic bacterial barrier that helps to relieve infection.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antibacterial Haemostatic Gels Market By Product Type, By Animal Type, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Antibacterial Haemostatic Gels Market Variables, Trends and Scope

    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
        

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antibacterial Haemostatic Gels Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antibacterial Haemostatic Gels Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antibacterial Haemostatic Gels Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Urinanalysis Testing Kits
        2. Hematology Testing Kits
        3. Blood Pressure Monitoring Devices
        4. Blood Glucose Monitoring Devices
        5. Others

  • 8.   Global Antibacterial Haemostatic Gels Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Cats
        2. Dogs
        3. Horses
        4. Others

  • 9.   Global Antibacterial Haemostatic Gels Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Homecare
        2. Diagnostic Centres
        3. Hospitals
        4. Clinics
        5. Others

  • 10.   North America Antibacterial Haemostatic Gels Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Antibacterial Haemostatic Gels Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Antibacterial Haemostatic Gels Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Antibacterial Haemostatic Gels Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Medura
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Zoetis Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. IDEXX laboratories inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

Related Market

Haemostatic Agents Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11